Cellfoundry Bio

Cellfoundry Bio is a biotechnology company focused on the development of a non-viral, microfluidic engine designed to democratize access to advanced immunotherapies. By providing shared infrastructure for cell therapy fabrication, the organization aims to accelerate the development and production of next-generation medicines, effectively applying the model of semiconductor foundries to the field of cell therapy. The company is based in Dallas, Texas, and was founded in 2026.

This technology platform serves to support cell therapy innovators by enhancing the efficiency and speed of therapy manufacturing. By focusing on microfluidic-based solutions, Cellfoundry Bio seeks to streamline the transition from research to clinical applications, addressing systemic challenges in the manufacturing of complex immunotherapies to ensure they can be produced at the speed of care.